GEP20043181B - Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies - Google Patents

Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies

Info

Publication number
GEP20043181B
GEP20043181B GEAP20006120A GEAP2000006120A GEP20043181B GE P20043181 B GEP20043181 B GE P20043181B GE AP20006120 A GEAP20006120 A GE AP20006120A GE AP2000006120 A GEAP2000006120 A GE AP2000006120A GE P20043181 B GEP20043181 B GE P20043181B
Authority
GE
Georgia
Prior art keywords
alkyl
optionally substituted
progesterone
treatment
aryl
Prior art date
Application number
GEAP20006120A
Other languages
English (en)
Inventor
James P Edwards
Lin Zhi
Andrew Fensome
Puwen Zhang
Mark A Collins
Christopher M Tegley
Todd K Jones
Jay E Wrobel
Eugene A Terefenko
Original Assignee
Wyeth Corp
Ligand Pharmaceuticals Inc Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by Wyeth Corp, Ligand Pharmaceuticals Inc Us filed Critical Wyeth Corp
Publication of GEP20043181B publication Critical patent/GEP20043181B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GEAP20006120A 1999-05-04 2000-05-01 Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies GEP20043181B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
GEP20043181B true GEP20043181B (en) 2004-02-25

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP20006120A GEP20043181B (en) 1999-05-04 2000-05-01 Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies

Country Status (24)

Country Link
EP (1) EP1175411B1 (cg-RX-API-DMAC10.html)
JP (2) JP4958338B2 (cg-RX-API-DMAC10.html)
KR (1) KR100732692B1 (cg-RX-API-DMAC10.html)
CN (1) CN1131856C (cg-RX-API-DMAC10.html)
AT (1) ATE386729T1 (cg-RX-API-DMAC10.html)
AU (1) AU766801B2 (cg-RX-API-DMAC10.html)
BG (1) BG65277B1 (cg-RX-API-DMAC10.html)
BR (1) BR0010214A (cg-RX-API-DMAC10.html)
CA (1) CA2371712C (cg-RX-API-DMAC10.html)
CZ (1) CZ20013952A3 (cg-RX-API-DMAC10.html)
DE (1) DE60038108T2 (cg-RX-API-DMAC10.html)
DK (1) DK1175411T3 (cg-RX-API-DMAC10.html)
EA (1) EA004511B1 (cg-RX-API-DMAC10.html)
ES (1) ES2301482T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20043181B (cg-RX-API-DMAC10.html)
HU (1) HUP0203332A3 (cg-RX-API-DMAC10.html)
IL (1) IL146298A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011287A (cg-RX-API-DMAC10.html)
NO (1) NO321370B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515353A (cg-RX-API-DMAC10.html)
PL (1) PL351083A1 (cg-RX-API-DMAC10.html)
SG (1) SG120970A1 (cg-RX-API-DMAC10.html)
SK (1) SK15922001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103285T2 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
JP4950027B2 (ja) * 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
AR049707A1 (es) * 2004-07-07 2006-08-30 Wyeth Corp Regimenes y kits de progestina ciclica
AU2005272854B2 (en) * 2004-08-13 2012-04-26 Wyeth Tanaproget derivatives, metabolites, and uses thereof
BRPI0610438A2 (pt) 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
US7767668B2 (en) * 2005-04-28 2010-08-03 Wyeth Llc Micronized tanaproget, compositions, and methods of preparing the same
ES2431324T3 (es) * 2005-04-28 2013-11-26 Wyeth Llc Forma purificada de tanaproget
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Also Published As

Publication number Publication date
SK15922001A3 (sk) 2002-09-10
PL351083A1 (en) 2003-03-10
IL146298A0 (en) 2002-07-25
HUP0203332A2 (hu) 2003-01-28
JP2002543192A (ja) 2002-12-17
JP5523430B2 (ja) 2014-06-18
EA200101181A1 (ru) 2002-04-25
DK1175411T3 (da) 2008-06-09
NO20015381D0 (no) 2001-11-02
KR20020000170A (ko) 2002-01-04
NO20015381L (no) 2002-01-03
AU766801B2 (en) 2003-10-23
CA2371712C (en) 2009-12-22
DE60038108D1 (de) 2008-04-03
TR200103285T2 (tr) 2002-02-21
SG120970A1 (en) 2006-04-26
NO321370B1 (no) 2006-05-02
DE60038108T2 (de) 2009-02-12
JP4958338B2 (ja) 2012-06-20
EP1175411A1 (en) 2002-01-30
EA004511B1 (ru) 2004-04-29
JP2012087129A (ja) 2012-05-10
MXPA01011287A (es) 2003-07-14
ES2301482T3 (es) 2008-07-01
KR100732692B1 (ko) 2007-06-27
CZ20013952A3 (cs) 2002-05-15
BG106080A (en) 2002-05-31
AU4811900A (en) 2000-11-17
EP1175411B1 (en) 2008-02-20
BG65277B1 (bg) 2007-11-30
NZ515353A (en) 2004-03-26
CA2371712A1 (en) 2000-11-09
HUP0203332A3 (en) 2004-12-28
CN1131856C (zh) 2003-12-24
CN1349516A (zh) 2002-05-15
BR0010214A (pt) 2002-02-13
ATE386729T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
SG120970A1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
HUP0300641A2 (hu) Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények
BR0109855A (pt) Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5
HUP9801688A2 (hu) Acetamidszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
HUP9900616A2 (hu) Triciklusos vegyületek, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
ATE204269T1 (de) Substituierte biphenyl- oder phenylpyridinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
NO994452D0 (no) Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse
BR0014901A (pt) Derivados de trifenil-alquenos e seu uso como moduladores de receptores seletivos de estrogênios
HUP9901820A2 (hu) 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
PL313075A1 (en) Heterocyclic compounds used as antagonistic substances in respect to neurokinin
AR034203A1 (es) Derivados de 1-aril- o 1-alquilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6, un metodo para su preparacion, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento
EE9700227A (et) Arüülglütsiinamiidi derivaadid, meetod nende valmistamiseks ja neid ühendeid sisaldavad farmatseutilised preparaadid
HUP9901096A2 (hu) Indolszármazékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
PL309281A1 (en) Derivatives of 1,4-benzodiazepine and their application as cck modulators
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
ZA988668B (en) Novel 5-membered ring heterocycles their preparation their use and pharmaceutical preparations comprising them
YU75394A (sh) Anelirani dihidropiridini i njihova primena za pripremanje farmaceutskih preparata
ATE18221T1 (de) (1-arylcyclobutyl)(heterocyclyl)methylaminderivate, ihre herstellung und ihre verwendung als arzneimittel.
NZ515355A (en) Cyclocarbamate derivatives as progesterone receptor modulators
JPS6470412A (en) Medicinal composition
GEP20043221B (en) Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Pharmaceutical Composition Containing Them and Use Thereof for Treatment Progesterone-Related Maladies.